1887
Volume 2014, Issue 4
  • ISSN: 2305-7823
  • E-ISSN:

There is no abstract available for this article.

Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2014.48
2015-03-01
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2014/4/gcsp.2014.48.html?itemId=/content/journals/10.5339/gcsp.2014.48&mimeType=html&fmt=ahah

References

  1. [1]. Davis   HR., , Zhu   L-J., , Hoos   LM., , Tetzloff   G., , Maguire   M., , Liu   J., , Yao   X., , Iyer   SP., , Lam   MH., , Lund   EG., , Detmers   PA., , Graziano   MP., , Altmann   SW. . Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. . J. Biol. Chem.   2004; ;279: 32 : 33586– 33592 .
    [Google Scholar]
  2. [2]. Davies   JP., , Levy   B., , Ioannou   YA. . Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1. . Genomics . 2000; ;65: 2 : 137– 145 .
    [Google Scholar]
  3. [3]. Carstea   ED., , Morris   JA., , Coleman   KG., , Loftus   SK., , Zhang   D., , Cummings   C., , Gu   J., , Rosenfeld   MA., , Pavan   WJ., , Krizman   DB., , Nagle   J., , Polymeropoulos   MH., , Sturley   SL., , Ioannou   YA., , Higgins   ME., , Comly   M., , Cooney   A., , Brown   A., , Kaneski   CR., , Blanchette-Mackie   EJ., , Dwyer   NK., , Neufeld   EB., , Chang   TY., , Liscum   L., , Strauss   JF 3rd., , Ohno   K., , Zeigler   M., , Carmi   R., , Sokol   J., , Markie   D., , O'Neill   RR., , van Diggelen   OP., , Elleder   M., , Patterson   MC., , Brady   RO., , Vanier   MT., , Pentchev   PG., , Tagle   DA. . Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. . Science . 1997; ;277: 5323 : 228– 231 .
    [Google Scholar]
  4. [4]. Cohen   J., , Pertsemlidis   A., , Kotowski   IK., , Graham   R., , Garcia   CK., , Hobbs   HH. . Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. . Nat. Genet.   2005; ;37: 2 : 161– 165 .
    [Google Scholar]
  5. [5]. Garcia-Calvo   M., , Lisnock   J., , Bull   HG., , Hawes   BE., , Burnett   DA., , Braun   MP., , Crona   JH., , Davis   HR Jr., , Dean   DC., , Detmers   PA., , Graziano   MP., , Hughes   M., , Macintyre   DE., , Ogawa   A., , O'neill   KA., , Iyer   SP., , Shevell   DE., , Smith   MM., , Tang   YS., , Makarewicz   AM., , Ujjainwalla   F., , Altmann   SW., , Chapman   KT., , Thornberry   NA. . The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). . Proc. Natl. Acad. Sci. U.S.A . 2005; ;102: 23 : 8132– 8137 .
    [Google Scholar]
  6. [6]. Ballantyne   CM., , Houri   J., , Notarbartolo   A., , Melani   L., , Lipka   LJ., , Suresh   R., , Sun   S., , LeBeaut   AP., , Sager   PT., , Veltri   EP. . Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. . Circulation . 2003; ;107: 19 : 2409– 2415 .
    [Google Scholar]
  7. [7]. Ezzet   F., , Wexler   D., , Statkevich   P., , Kosoglou   T., , Patrick   J., , Lipka   L., , Mellars   L., , Veltri   E., , Batra   V. . The plasma concentration and LDL-C relationship in patients receiving ezetimibe. . J. Clin. Pharmacol.   2001; ;41: 9 : 943– 949 .
    [Google Scholar]
  8. [8]. Davidson   MH., , McGarry   T., , Bettis   R., , Melani   L., , Lipka   LJ., , LeBeaut   AP., , Suresh   R., , Sun   S., , Veltri   EP. . Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. . J. Am. Coll. Cardiol.   2002; ;40: 12 : 2125– 2134 .
    [Google Scholar]
  9. [9]. Raal   FJ., , Stein   EA., , Dufour   R., , Turner   T., , Civeira   F., , Burgess   L., , Langslet   G., , Scott   R., , Olsson   AG., , Sullivan   D., , Hovingh   GK., , Cariou   B., , Gouni-Berthold   I., , Somaratne   R., , Bridges   I., , Scott   R., , Wasserman   SM., , Gaudet   D. . PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial. . Lancet . 2014; ;   doi:10.1016/S0140-6736(14)61399-4   October .
    [Google Scholar]
  10. [10]. Robinson   JG., , Nedergaard   BS., , Rogers   WJ., , Fialkow   J., , Neutel   JM., , Ramstad   D., , Somaratne   R., , Legg   JC., , Nelson   P., , Scott   R., , Wasserman   SM., , Weiss   R. . Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia The LAPLACE-2 Randomized Clinical Trial. . JAMA . 2014; ;311: 18 : 1870– 1882 .
    [Google Scholar]
  11. [11]. Kaye   T. . Simvastatin with or without ezetimibe in familial hypercholesterolemia. . N. Engl. J. Med.   2008; ;359: 5 : 531– 532 .
    [Google Scholar]
  12. [12]. Reiner   Z., , Catapano   AL., , De Backer   G., , Graham   I., , Taskinen   MR., , Wiklund   O., , Agewall   S., , Alegria   E., , Chapman   MJ., , Durrington   P., , Erdine   S., , Halcox   J., , Hobbs   R., , Kjekshus   J., , Filardi   PP., , Riccardi   G., , Storey   RF., , Wood   D., , European Association for Cardiovascular Prevention&Rehabilitation. . ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). . Eur. Heart J.   2011; ;32: 14 : 1769– 1818 .
    [Google Scholar]
  13. [13]. Stone   NJ., , Robinson   JG., , Lichtenstein   AH., , Bairey Merz   CN., , Blum   CB., , Eckel   RH., , Goldberg   AC., , Gordon   D., , Levy   D., , Lloyd-Jones   DM., , McBride   P., , Schwartz   JS., , Shero   ST., , Smith   SC Jr., , Watson   K., , Wilson   PW. . ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. . J. Am. Coll. Cardiol . 2014; ;63: 25 : 2889– 2934 .
    [Google Scholar]
  14. [14]. The Myocardial Infarction Genetics Consortium Investigators . Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease. . N. Engl. J. Med.   2014; ;   Epub ahead of print .
    [Google Scholar]
  15. [15]. Blazing   MA., , Giugliano   RP., , Cannon   CP., , Musliner   TA., , Tershakovec   AM., , White   JA., , Reist   C., , McCagg   A., , Braunwald   E., , Califf   RM. . Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population. . Am. Heart J.   2014; ;168: 2 : 205– 12e1 .
    [Google Scholar]
  16. [17]. Plenge   RM., , Scolnick   EM., , Altshuler   D. . Validating therapeutic targets through human genetics. . Nat. Rev. Drug Discov.   2013; ;12: 8 : 581– 594 .
    [Google Scholar]
  17. [18]. Ikonen   E. . Cellular cholesterol trafficking and compartmentalization. . Nat. Rev. Mol. Cell Bio.   2008; ;9: : 125– 138 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2014.48
Loading
/content/journals/10.5339/gcsp.2014.48
Loading

Data & Media loading...

  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error